AIRLINK 65.69 Decreased By ▼ -0.21 (-0.32%)
BOP 5.68 Decreased By ▼ -0.01 (-0.18%)
CNERGY 4.62 Decreased By ▼ -0.03 (-0.65%)
DFML 23.05 Increased By ▲ 0.20 (0.88%)
DGKC 71.01 Increased By ▲ 0.31 (0.44%)
FCCL 20.74 Increased By ▲ 0.39 (1.92%)
FFBL 28.70 Decreased By ▼ -0.41 (-1.41%)
FFL 9.90 Decreased By ▼ -0.03 (-0.3%)
GGL 10.09 Increased By ▲ 0.01 (0.1%)
HBL 116.50 Increased By ▲ 1.25 (1.08%)
HUBC 130.00 Increased By ▲ 0.50 (0.39%)
HUMNL 6.64 Decreased By ▼ -0.06 (-0.9%)
KEL 4.55 Increased By ▲ 0.17 (3.88%)
KOSM 5.07 Increased By ▲ 0.05 (1%)
MLCF 37.50 Increased By ▲ 0.54 (1.46%)
OGDC 133.00 Increased By ▲ 1.80 (1.37%)
PAEL 22.76 Increased By ▲ 0.28 (1.25%)
PIAA 26.07 Decreased By ▼ -0.23 (-0.87%)
PIBTL 6.47 Decreased By ▼ -0.06 (-0.92%)
PPL 113.50 Increased By ▲ 1.38 (1.23%)
PRL 28.34 Decreased By ▼ -0.05 (-0.18%)
PTC 16.25 Increased By ▲ 0.14 (0.87%)
SEARL 57.73 Decreased By ▼ -0.56 (-0.96%)
SNGP 66.20 Increased By ▲ 0.51 (0.78%)
SSGC 11.09 Increased By ▲ 0.07 (0.64%)
TELE 8.95 Increased By ▲ 0.01 (0.11%)
TPLP 11.83 Increased By ▲ 0.30 (2.6%)
TRG 69.40 Increased By ▲ 0.16 (0.23%)
UNITY 23.79 Decreased By ▼ -0.16 (-0.67%)
WTL 1.40 Increased By ▲ 0.05 (3.7%)
BR100 7,330 Increased By 25.5 (0.35%)
BR30 24,139 Increased By 188.6 (0.79%)
KSE100 70,588 Increased By 254.9 (0.36%)
KSE30 23,198 Increased By 77.9 (0.34%)

KARACHI: In line with our vision to be trusted global healthcare partner - CCL in Vietnam has ventured into an exclusive marketing and distribution agreement, leading to a joint venture, with AJRP Malaysia – a Global Healthcare Conglomerate”, shares Atif Siddiqui, President CCL Life Sciences.

The contract was signed on 1st April 2021 by Jaudat Amin – Business Head CCL South East Asia and D.S. Jamil Bidin – CEO AJRP Malaysia. CCL envisions to meet everyday health, nutrition, home and personal care needs of a billion people in developing countries – making them happy, feel good and get more out of life. To be able to do so, we aspire to be trusted global healthcare partners, offering unique solutions for all stages of life.

CCL has a legacy of over 50 years, with a global footprint in 22 countries and counting. We specialize in pharmaceuticals, consumer healthcare, food and nutrition and digital health products. Our strategic partners have a proven track record of over 70 years, operating in healthcare, life sciences, food and beverage, oil and gas and the automotive sector. Together, we aim to bring quality life products to our consumers, and contribute towards strengthening the Global Consumer Healthcare portfolio in the region.—PR

Copyright Business Recorder, 2021

Comments

Comments are closed.